What is NDC 63323-142?

63323-142 is the product NDC for Ifosfamide, Ifosfamide 1 g/1 injection, powder, lyophilized, for solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ifosfamide?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ifosfamide NDC 63323-142 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-142Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0142Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-142-10	63323014210	1 VIAL, SINGLE-DOSE in 1 BOX (63323-142-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSEMarketed from Jan 28, 2003

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ifosfamide
Generic name (nonproprietary): ifosfamide
Active ingredients: Ifosfamide — 1 g/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Fresenius Kabi USA, LLCNDC labeler code 63323
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076078
Marketing start: Jan 28, 2003
Listing expires: Dec 31, 2027
Other FDA classes: Alkylating Activity (Mechanism)
Identifiers: Product ID 63323-142_8f166a04-4395-4ea1-8eda-98274f1bfec3SPL ID 8f166a04-4395-4ea1-8eda-98274f1bfec3SPL set ID a311a947-7b78-4226-bfe0-f4aa0be20e27RxCUI 1791593UNII UM20QQM95Y
Pharmacologic class: Alkylating Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323014210 followed by a unit qualifier and the quantity

Package 63323-0142-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 9, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Ifosfamide for Injection is indicated for use in combination with certain other approved antineoplastic agents for third-line chemotherapy of germ cell testicular cancer. It should be used in combination with mesna for prophylaxis of hemorrhagic cystitis. Ifosfamide for Injection is an alkylating drug indicated for use in combination with certain other approved antineoplastic agents for third-line chemotherapy of germ cell testicular cancer. It should be used in combination with mesna for prophylaxis of hemorrhagic cystitis. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63323-142

What is NDC 63323-142?: 63323-142 is the product NDC for Ifosfamide, Ifosfamide 1 g/1 injection, powder, lyophilized, for solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ifosfamide.
What is the active ingredient?: Ifosfamide.
Who is the labeler?: Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ifosfamide?: 7 other product NDCs are listed under this name. See all Ifosfamide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ifosfamide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ifosfamideifosfamide for injection	Ifosfamide 1 g/1	Powder, For solutionIntravenous	SteriMax Inc.	21586-211	21586-0211-02
Ifosfamide	Ifosfamide 50 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9530	00143-9530-01
Ifosfamide	Ifosfamide 50 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9531	00143-9531-01
Ifosfamide	Ifosfamide 3 g/60mL	Injection, Powder, For solutionIntravenous	Baxter Healthcare Company	10019-929	10019-0929-03
Ifosfamide	Ifosfamide 1 g/20mL	Injection, Powder, For solutionIntravenous	Baxter Healthcare Company	10019-925	10019-0925-01
Ifosfamide	Ifosfamide 3 g/60mL	Injection, Powder, For solutionIntravenous	Baxter Healthcare Company	10019-926	10019-0926-02
Ifosfamide	Ifosfamide 1 g/20mL	Injection, Powder, For solutionIntravenous	Baxter Healthcare Company	10019-927	10019-0927-01